Vimarsana
Biggest News Aggregation in the World

Page 7 - I Malignancy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from I Malignancy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In I Malignancy Today - Breaking & Trending Today

Can Immunotherapy Replace Surgery for Stomach Cancer? - Vimarsana News

Can Immunotherapy Replace Surgery for Stomach Cancer?

In a small study, just over half (59%) of patients who had combination immunotherapy showed no sign of tumor on preoperative endoscopy.

Decades of Research Fail to Resolve Disparities in GI Cancer Care - Vimarsana News

Decades of Research Fail to Resolve Disparities in GI Cancer Care

Men and White people receive better treatment for gastroesophageal cancer than women, Blacks, and Latinos despite years of studies highlighting disparities in care, researchers say.

ctDNA Identifies CRC Patients Who Benefit From Adjuvant Therapy - Vimarsana News

ctDNA Identifies CRC Patients Who Benefit From Adjuvant Therapy

A blood test that measures circulating tumor DNA can identify patients with colorectal cancer who may derive the most benefit from adjuvant chemotherapy.

Adding TACE to Lenvatinib Improves Survival in Liver Cancer - Vimarsana News

Adding TACE to Lenvatinib Improves Survival in Liver Cancer

Transarterial chemoembolization (TACE) added onto lenvatinib is a new first-line option for patients with advanced liver cancer, say LAUNCH trialists.

Potential New Standard of Care for Biliary Tract Cancer - Vimarsana News

Potential New Standard of Care for Biliary Tract Cancer

Interim data from a large phase 3 trial show that adding durvalumab to chemotherapy significantly improved overall survival vs chemotherapy alone.